Patient Characteristics and Imaging Data
| Patient no. | Age (y) | Sex | Tumor differentiation* | Stage at surgery† | Histology‡ | 18F-FDG SUVmax (T)§ | 18F-FMISO SUVmax (T)‖ | 18F-FMISO T/N¶ |
|---|---|---|---|---|---|---|---|---|
| 1 | 72 | F | Moderate | I (T1 N0 M0) | Adeno Ca | 3.50 | 1.0 | 1.67 |
| 2 | 68 | M | Moderate | I (T1 N0 M0) | Adeno Ca | 2.80 | 1.3 | 1.18 |
| 3 | 51 | M | Moderate | II (T1 N1 M0) | Adeno/SCC | 5.90 | 1.0 | 2.00 |
| 4 | 69 | M | Poor | I (T1 N0 M0) | Adeno Ca | 4.50 | 1.25 | 1.98 |
| 5 | 66 | M | Poor | I (T1 N0 M0) | Adeno Ca | 4.15 | 1.10 | 2.20 |
| 6 | 59 | M | Poor | I (T1 N0 M0) | Adeno Ca | 9.38 | 1.70 | 4.25 |
| 7 | 69 | M | Poor | I (T1 N0 M0) | Adeno Ca | 6.40 | 0.80 | 1.60 |
| 8 | 77 | M | Moderate | I (T1 N0 M0) | Adeno/SCC | 2.91 | 0.91 | 3.25 |
| 9 | 71 | M | Moderate | I (T1 N0 M0) | Adeno Ca | 7.20 | 0.86 | 2.32 |
| 10 | 73 | M | Moderate | II (T1 N1 M0) | SCC | 8.30 | 1.74 | 4.46 |
| 11 | 66 | M | Poor | I (T1 N0 M0) | Adeno Ca | 2.63 | 0.75 | 4.41 |
| 12 | 70 | M | Moderate | I (T1 N0 M0) | SCC | 8.72 | 0.59 | 5.36 |
| 13 | 69 | M | Moderate | I (T1 N0 M0) | SCC | 6.54 | 0.40 | 2.86 |
| 14 | 58 | F | Well | I (T1 N0 M0) | Adeno Ca | 2.16 | 1.61 | 5.75 |
| 15 | 63 | F | Moderate | I (T1 N0 M0) | Adeno Ca | 8.53 | 2.14 | 9.73 |
| 16 | 75 | F | Poor | I (T1 N0 M0) | Adeno Ca | 10.46 | 1.46 | 5.21 |
| 17 | 63 | M | Moderate | I (T1 N0 M0) | Adeno Ca | 7.71 | 1.82 | 5.06 |
↵* Well, moderate, or poorly differentiated tumor.
↵† Based on American Joint Committee on Cancer NSCLC staging system (2002).
↵‡ Adeno Ca = adenocarcinoma; Adeno/SCC = mixed adenocarcinoma/squamous carcinoma; SCC = squamous cell carcinoma.
↵§ 18F-FDG SUVmax in tumor.
↵‖ 18F-FMISO SUVmax in tumor.
↵¶ 18F-FMISO SUVmax in tumor/18F-FMISO SUVmax uptake in normal lung.